BeiGene
BGNE
#940
Rank
HK$157.35 B
Marketcap
HK$1,438
Share price
0.49%
Change (1 day)
1.40%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: HK$3,139 HKD on 2021-09-17

Lowest end of day price: HK$186.72 HKD on 2016-02-12

Stock price history of BeiGene from 2016 to 2025

201920222025$500$1000$1500$2000$2500$3000companiesmarketcap.com

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
HK$7.75-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.45-0.68%๐Ÿ‡บ๐Ÿ‡ธ USA